NextSDSNeed to manage your chemicals?Discover NextSDS →
(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8 structure

(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8

Name

(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8

Molecular Formula

C18H24ClNO3

Identifiers

cas number90274-24-1PRIMARY
ec number415-170-5
chemical nameRactopamine hydrochloride
chemical name(±)-4-[2-[[3-(4-hydroxyphenyl)-1-methylpropyl]amino]-1-hydroxyethyl]phenol hydrochloride PAYLEAN; RACTOPAMINE HYDROCHLORIDE 604-068-00-8

GHS Hazard Pictograms

GHS07 Hazard PictogramGHS07

Hazard Classifications

Acute Tox. 4
Warning
Acute toxicity (oral + dermal + inhalation)
Hazard Code:H302 + H312 + H332
Category:Acute Tox. 4
Source: Harmonised C&L
Skin Sens. 1
Warning
Skin sensitisation
Hazard Code:H317
Category:Skin Sens. 1
Source: Harmonised C&L

Regulatory Lists (2)

CLP ANNEX VI — HARMONISED CLASSIFICATION AND LABELLING
Substances with a harmonised classification and labelling in Annex VI of the CLP Regulation (EC) No 1272/2008. The classification is legally binding across the EU and overrides a supplier's own self-classification.
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out

Disclaimer

The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.